PO-0849: Heart structures sparing through volumetric modulated arc therapy in mediastinal Hodgkin lymphoma  by Filippi, A.R. et al.
S404                                                                                                                                                    ESTRO 35 2016 
______________________________________________________________________________________________________ 
1, 2 and 6 due to air within the PTV_SIP volumes compared 
with the other patients. Safety of the plans was analysed 
from the absolute volume DVHs (dose to mL). The steepness 
of dose fall off could be read off by the comparing the doses 
to the PRVs with those to the OARs. The constraints were 
respected for the corresponding OARs. All patients had local 
control at a median follow-up of 9 months and toxicity was 
low. 
 
Conclusion: SIP-IMRT is shown to result in a median dose of 
≥100% to PTV_Σ, to achieve high local control and low 
toxicity. Longer follow-up is required for verification of these 
results and a prospective clinical trial is currently testing this 
new approach in chest and abdomen SBRT. 
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Purpose or Objective: Within the frame of further 
implementing a precise dose delivery in young patients with 
mediastinal Hodgkin lymphoma, heart sparing appears a 
crucial endpoint. Recent studies demonstrated a correlation 
between the occurrence of various late events (e.g. heart 
failure, myocardial infarction, valve disease) and the dose 
received by different cardiac substructures, giving insights 
into a complex mechanism of radiation-induced toxicity. The 
purpose of this study was to compare the dose received by 
these substructures either using an optimized multi-arcs 
volumetric arc therapy (VMAT) or classical 3D-CRT.  
 
Material and Methods: We analyzed the plans of 14 patients 
(3 males and 11 females) with stage I-IIA mediastinal disease 
without axillary involvement, treated with involved site 
radiotherapy; 11 had a bulky presentation at diagnosis. In 
every patient, a deformable fusion was performed with a 
dedicated software (Velocity™, Varian) between the planning 
CT scan and the pre-radiotherapy contrast enhanced CT scan. 
The following structures were delineated: whole heart; left 
main, left descending, circumflex and right coronary arteries; 
aortic, pulmonary, mitral and tricuspid valves; right and left 
atria; right ventricle, left ventricle and inter-ventricular 
septum; left ventricular apex, mid cavity, base and lateral 
wall. Two experienced radiation oncologists contoured target 
volumes (CTV) and heart structures, after a training session 
with a cardiologist and a heart radiologist. 3DCRT was 
planned as AP-PA, while the VMAT approach consisted of 
multi non-coplanar arcs (the so-called butterfly technique). 
Mean and max dose received by the single substructures were 
compared by Student’s T test.  
 
Results: Mean and max doses for the different cardiac 
structures,, according to the technique used, are reported in 
table 1. Maximum dose resulted similar for almost all the 
structures except for the whole heart and the right ventricle, 
where VMAT gave higher doses (probably due to small 
hotspots in the PTV areas adherent to heart segments, mainly 
located in the lower anterior mediastinum). Conversely, a 
lower mean dose was delivered by using VMAT to all 
structures, reaching a strong significant difference for whole 
heart (p = 0.025), aortic valve (p<0.0001), mitral valve 
(p=0.049) and left atrium (p<0.0001). Most significant 
findings are illustrated in figure 1.  
 
 
 
 
 
Conclusion: In this preliminary dosimetric comparison, 
optimized multi arcs VMAT was able to significantly reduce 
the mean dose to crucial heart substructures such as aortic 
valve, with a generalized reduction in mean doses received 
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by other substructures. The potential clinical benefits still 
need to be demonstrated in expanded cohorts, with 
prolonged life-long follow-up. 
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Purpose or Objective: This study aims to investigate how 
much fractionation, and the different delivery dynamics of 
higher dose-per-fraction deliveries, can influence the impact 
of interplay effects for PBS-based lung tumour treatments. 
 
Material and Methods: For two example lung tumour cases (I 
and II), three-field 3D plans were calculated on a patient 
specific range-adapted ITV (rITV) using a spot spacing of 4mm 
orthogonal to the beam directions. 4D dose calculations were 
performed, simulating three different fractionation 
treatments with schemes of (A)2.5Gyx35fx, (B)5Gyx10fx and 
(C)13.5Gyx3fx, based on machine and delivery parameters of 
the Varian ProBeam system (lateral scanning speed of 5/20 
mm/ms and energy switching time of 700 ms with layer-wise 
optimized dose rates). 1x- to 10x- layered and volumetric 
rescanning was simulated to mitigate residual motion effects. 
The final dose distributions for fractioned treatments were 
obtained by superposition and normalization of the 4D dose 
distributions of each field and each fraction with random 
starting phases sampled from 4DCT (10 different phases with 
100 random starts). We used homogeneity index (HI:D5-D95) 
in the CTV to quantify the resultant 4D dose distributions 
within the target, while for the normal lung (both lungs 
minus CTV), V20, mean lung dose (MLD) and D2 were 
compared. 
 
Results: For single fraction only delivery (shown by error bars 
with hollow markers in figure a), the normalized HIs are 
similar for the different fraction doses for both patients, with 
HI being typically 14/15% higher than the static for case I and 
II respectively. For the full treatments (solid markers), the 
normalized HIs of plans under scheme A and B are equal or 
better than for the static plan, with only ±1.2% variations as 
a function of starting phase. In addition, whereas for scheme 
C, HI is 2.5±2.6/4.8±2.3% (Case I/II) higher than the static 
case, this also reaches comparable homogeneity as the static 
case once combined with moderate rescanning (<5x). 
Variability is also reduced to within 1%, independent of the 
rescanning technique used. Concerning treatment time, for 
single fractions, nearly no difference can be seen among the 
different schemes when no rescanning is applied, due to the 
layer-wise optimized dose rate used by the ProBeam system. 
For 5x LS or VS, treatment time is increased by 100% and 37% 
respectively for scheme C in comparison to scheme A, 
although the absolute treatment time for LS is always less 
than half that of VS for all schemes. For the whole 
treatment, more than 75% reduction of time cost can be 
obtained once fractionation scheme (C) is used. 
 
 
 
Conclusion: For PBS-based lung tumour proton therapy, 
fractionation can lead to an improved target homogeneity, 
and variability as a function of starting phase is only obvious 
when large fraction doses are used and can be reduced with 
moderate (<5x) rescanning is applied. 
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Purpose or Objective: One of the major limitations of IOERT 
is the lack of a postoperative image based treatment 
planning, in order to optimize the radiotherapy procedure. 
The aim of this study is to develop and introduce a 
postoperative image based treatment planning system for 
breast cancer IOERT. 
 
Material and Methods; to obtain a postoperative image 
based treatment planning software, it is necessary to have a 
postoperative image which includes the anatomical 
modifications of the tumor bed after the surgery. To this 
end, a C-arm fluoroscopy system (Zeihm Vision-8000) was 
employed to obtain a series of 2D images which include the 
tumor bed together with the IORT applicator and protection 
disk.In addition to the postoperative images, it is mandatory 
to have the complete isodose distributions for different 
combinations of applicator size/energy. To obtain this data, 
Monte Carlo simulation was employed. The LIAC IORT 
accelerator was simulated by MCNPX code and then, isodose 
distributions were extracted using mesh tally inside a water 
phantom. To develop a graphical treatment planning 
software, a graphical user interface (GUI) was prepared by an 
in house program written with MATLAB. At first, the 
postoperative image is imported to the program. Then, the 
corresponding isodose distribution file is loaded to the 
program. Then, the user will specify the applicator edge and 
program registers the isodose curves to the postoperative 
image. In order to evaluate the performance accuracy of the 
implemented postoperative image based treatment plans and 
delivered dose to the patient, in vivo dosimetry was used. To 
this end, the delivered dose to the surface of tumor bed was 
measured by Gafchromic EBT2 film. 
 
Results: The result of intraopertaive imaging and 
corresponding treatment planning is shown in Fig. 1. 
 
